-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AP-301 in Hyperphosphatemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AP-301 in Hyperphosphatemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AP-301 in Hyperphosphatemia Drug Details: VS-505 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AP-472 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AP-472 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AP-472 in Parkinson's Disease Drug Details: AP-472 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AP-306 in Hyperphosphatemia In Chronic Kidney Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AP-306 in Hyperphosphatemia In Chronic Kidney Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AP-306 in Hyperphosphatemia In Chronic Kidney Disease Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AP-31969 in Atrial Fibrillation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AP-31969 in Atrial Fibrillation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AP-31969 in Atrial Fibrillation Drug Details: AP-31969 is under development for the...
-
Company Insights
NewHuawei Pay – Competitor Profile
Huawei Pay was launched in 2016 via a collaboration between payment scheme China UnionPay and smartphone brand Huawei, with the aim of competing in China’s exponentially expanding mobile payments market. Huawei Pay offers a ranges of payment services, including in-app and in-store payments. It offers both NFC payment as well as QR code payments for in-store purchases. To ensure privacy and security for payments, Huawei Pay utilizes tokenization and biometric authentication such as fingerprint recognition. Challenging the dominance of established...
-
Company Insights
Innovation and Patenting activity of AP Memory Technology Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AP Memory Technology Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AP-303 in Diabetic Nephropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AP-303 in Diabetic Nephropathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AP-303 in Diabetic Nephropathy Drug Details: AP-303 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LX-001 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-001 in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-001 in Prostate Cancer Drug Details: AP-002 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LX-001 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-001 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-001 in Breast Cancer Drug Details: AP-002 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LX-001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-001 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-001 in Non-Small Cell Lung Cancer Drug Details: AP-002 is...